Jacobsen Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Jacobsen Capital Management's PFE Position: Q3 2026 in Review
Jacobsen Capital Management reduced its Pfizer (PFE) stake by 3.5% in Q3 2026, selling an estimated $9.8K and leaving 10,081 shares worth $287K. The position accounts for 0.08% of the portfolio, ranked #96.
Jacobsen Capital Management first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $308K in Q1 2026. 2,346 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Jacobsen Capital Management held 10,081 shares of Pfizer worth $287K as of Q3 2026.
- Jacobsen Capital Management sold 370 Pfizer shares in Q3 2026, an estimated $9.8K.
- Pfizer made up 0.08% of Jacobsen Capital Management's portfolio in Q3 2026, its #96 holding.
- Jacobsen Capital Management first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
- Jacobsen Capital Management's Pfizer position peaked at $308K in Q1 2026.
- 2,346 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Jacobsen Capital Management's 13F filing for Q3 2026, filed 27 Oct 2026.